Author

Mikiko Sakuragi

Institution: Osaka University Hospital

Observed institutions: Osaka University Hospital, The University of Osaka

OpenAlex ID: A5000527626

Clinical significance of IPF% or RP% measurement in distinguishing primary immune thrombocytopenia from aplastic thrombocytopenic disorders

2015 · Mikiko Sakuragi, Satoru Hayashi, et al. · International Journal of Hematology · 44

Distinct effects of daratumumab on indirect and direct antiglobulin tests: a new method employing 0.01 mol/L dithiothreitol for negating the daratumumab interference with preserving K antigenicity (Osaka method)

2018 · Mika Hosokawa, Hirokazu Kashiwagi, et al. · Transfusion · 31

Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation

2017 · Mikiko Sakuragi, Satoru Hayashi, et al. · International Journal of Hematology · 17

Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D−− phenotype

2019 · Kazuya Mimura, Masayuki Endo, et al. · International Journal of Hematology · 11

Additional validation of Osaka method (0.01 mol/L dithiothreitol) for negating the daratumumab interference

2019 · Mika Hosokawa, Hirokazu Kashiwagi, et al. · Transfusion · 6

Clinical Course of Alloimmunized Patients After Red Blood Cell Transfusion

2013 · Mikiko Sakuragi, Tomoko Kiyokawa, et al. · Japanese Journal of Transfusion and Cell Therapy · 5

Reducing Discarded Blood Components: Analysis of Reasons for Discard Over the Past 6 Years

2011 · Tamayo Ikeda, Machiko Oshida, et al. · Japanese Journal of Transfusion and Cell Therapy · 4

OSAKA METHOD (0.01 mol/l DTT) EFFECTIVELY NEGATES DARATUMUMAB INTERFERENCE: A PATIENT WITH MULTIPLE MYELOMA AND DIFFICULT-TO-OBTAIN PREVIOUS MEDICAL HISTORY

2019 · Mika Hosokawa, Hirokazu Kashiwagi, et al. · Japanese Journal of Transfusion and Cell Therapy · 2

A CASE OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA IN THE PRESENCE OF THREE DIFFERENT anti-HPA ANTIBODIES: HPA-4b, HPA-5a, AND HPA-15b ANTIBODIES

2018 · Tomoko Kiyokawa, Yongsook Koh, et al. · Japanese Journal of Transfusion and Cell Therapy · 2

A case of neonatal alloimmune thrombocytopenia in the presence of both anti-HPA-4b and anti-HPA-5b antibody: clinical and serological analysis of the subsequent pregnancy

2014 · Tomoko Kiyokawa, Yangsook Koh, et al. · International Journal of Hematology · 2

Results of Pre- and Post-transfusion Tests for Infectious Disease at Osaka University Hospital and Future Prospects

2020 · Tomoko Kiyokawa, Kotarosumitomo Nakayama, et al. · Japanese Journal of Transfusion and Cell Therapy · 1

Dtt Treatment for Strong Autoagglutination Observed in a Patient With Low-titer Cad

2017 · Mika Hosokawa, Kotarousumitomo Nakayama, et al. · Japanese Journal of Transfusion and Cell Therapy · 1

Effects of Rituximab Prophylaxis on the Amount of Ffp Used for Anti-abo Antibodies in Blood-type-incompatible Adult Living Donor Liver Transplantation

2016 · Mika Hosokawa, Kotarousumitomo Nakayama, et al. · Japanese Journal of Transfusion and Cell Therapy · 1

Direct Antiglobulin Testing of Patients With Multiple Myeloma Treated With Anti-cd38 Monoclonal Antibodies

2022 · Mika Hosokawa, Keisuke Nagamine, et al. · Japanese Journal of Transfusion and Cell Therapy

Efforts to Eliminate Incidents of Authentication Just Prior to Blood Transfusion: Surgery Support System Remodeling and Multidisciplinary Collaboration

2022 · Mayumi Nakao, Hiroshi Aochi, et al. · Japanese Journal of Transfusion and Cell Therapy

Similar Packaging Between Blood Transfusion and Infusion Sets and Ensuing Mix-up Incidents

2016 · Kotarosumitomo Nakayama, Mika Hosokawa, et al. · Japanese Journal of Transfusion and Cell Therapy

Works count: 16

Citation count: 127

H-index: 5

I10-index: 4